Rapilif-M 25 Tablet is used for the treatment of Benign prostatic hyperplasia (BPH), a condition in men that causes the enlargement of the prostate gland. It is complicated by an overactive bladder and symptoms of urge urinary incontinence (involuntary leakage of urine), urgency, and frequency.
Rapilif-M 25 Tablet contains Mirabegron and Silodosin. Mirabegron works by reducing the activity of an overactive bladder and treats related symptoms. Silodosin works by relaxing the muscles around the bladder exit and prostate gland. Thus, it makes it easier to pass urine and helps relieve urinary symptoms.
Take Rapilif-M 25 Tablet as prescribed. Your doctor will advise you on how often you should take it based on your medical condition. Rapilif-M 25 Tablet may cause common side effects such as abnormal ejaculation, increased heart rate, dizziness, nausea, constipation, urinary tract infections, and runny or blocked nose. Most of these side effects of Rapilif-M 25 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor.
If you are allergic to Mirabegron, Silodosin, or any other medicines, please tell your doctor. Rapilif-M 25 Tablet is not recommended for children and adolescents under 18 years of age. Drive only if you are alert after taking Rapilif-M 25 Tablet , as it may cause dizziness. If you are about to undergo cataract eye surgery, inform your eye specialist that you are taking Rapilif-M 25 Tablet , as it may cause complications during the surgery.